Minerva IPO Presentation Deck slide image

Minerva IPO Presentation Deck

Resectr Overview FDA-cleared in June 2016 Ergonomic handle Rotating cannula Outflow port Sheath DI Resection blade Key advantages of Resectr Cost-effective "Single Patient Use", manual surgical instrument works with existing hysteroscopy equipment Highly functional Enables hysteroscopic removal of polyps in a single in-office visit Comfort and convenience Does not require hospitalization Ť 28
View entire presentation